Transcription of US-19233 ------------------------- DOSAGE AND ...
{{id}} {{{paragraph}}}
US-19233 ------------------------- DOSAGE AND ADMINISTRATION -------------------------- highlights OF prescribing information Initiate treatment with 180 mg oral loading dose following an ACS event. Continue treatment with 90 mg twice daily during the first year after an ACS. These highlights do not include all the information needed to use brilinta . event. After one year, administer 60 mg twice daily. ( ). safely and effectively. See full prescribing information for brilinta . Use brilinta with a daily maintenance dose of aspirin of 75-100 mg. brilinta (ticagrelor) tablets, for oral use ( , ). Initial Approval: 2011. ------------------------ DOSAGE FORMS AND STRENGTHS ------------------------ 60 mg and 90 mg tablets (3). WARNING: (A) BLEEDING RISK, and (B) ASPIRIN DOSE AND. brilinta EFFECTIVENESS -------------------------------- CONTRAINDICATIONS ------------------------------- See full prescribing information for complete boxed warning.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}